TORNTPHARMPharmaceuticals
Torrent Pharmaceuticals Ltd — PE Ratio & Valuation Analysis
₹4220.20
-0.74%
Current P/E58.36xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E66.8x12.6% below avg
⚠️
83.7% Premium to Industry
TORNTPHARM P/E 58.36x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹56.47 | ₹3850 | 68.2x |
| 2024 | ₹48.94 | ₹3360 | 68.7x |
| 2023 | ₹36.79 | ₹2306 | 62.7x |
| 2022 | ₹22.96 | ₹1551 | 67.5x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Torrent Pharmaceuticals Ltd Valuation
Torrent Pharmaceuticals Ltd (TORNTPHARM) currently trades at 58.36x earnings. The Pharmaceuticals sector average PE is 31.77x. TORNTPHARM commands a premium, reflecting high growth expectations. Historically, TORNTPHARM has traded at an average PE of 66.8x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
26.52%
Dividend Yield
0.86%
More on Torrent Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.